Genetic Divergence of Hepatitis C Virus: The Role of HIV-Related Immunosuppression
- 1 October 2008
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 49 (2) , 136-141
Abstract
Background: We tested the hypothesis that HIV-related immunosuppression alters the host-hepatitis C virus (HCV) interaction, resulting in fewer amino acid-changing substitutions in HCV viral variants. Higher HCV RNA levels in persons coinfected with HIV compared with HCV infection alone suggest increased viral replication. If this increase is dependent on decreased immune selective pressure, then a reduced rate of nucleotide changes resulting in amino acid replacements (nonsynonymous changes, dN) would be expected. Methods: We investigated HCV envelope sequences over time in 79 persons with chronic HCV infection who were HIV negative (group 1) or HIV positive with (group 3) or without (group 2) severe immunodeficiency. We amplified a 1026-nt region of the HCV genome, which encodes a portion of the envelope glycoproteins E1 and E2, including hypervariable region-1 for direct sequence analysis. Results: The overall divergence between paired sequences, dS, dN, and dN/dS, all showed no significant differences among the 3 groups. Conclusions: By measuring nucleotide substitutions in HCV sequences over time, we found no significant differences in the genetic divergence between HCV-monoinfected control subjects and HIV/HCV-coinfected subjects with various levels of immunodeficiency as measured by CD4+ T-cell counts.Keywords
This publication has 34 references indexed in Scilit:
- HIV Infection and Antiretroviral Therapy: Effect on Hepatitis C Virus Quasispecies VariabilityThe Journal of Infectious Diseases, 2006
- Complexity and Diversity of Hepatitis C Virus RNA in African Americans and Whites: Analysis of the Envelope‐Coding DomainThe Journal of Infectious Diseases, 2004
- Hepatitis C Virus (HCV) Diversity in HIV‐HCV–Coinfected Subjects Initiating Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2004
- Impact of Highly Active Antiretroviral Therapy and Immunologic Status on Hepatitis C Virus Quasispecies Diversity in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsJournal of Virology, 2003
- Influence of CD4 Cell Counts on the Genetic Heterogeneity of Hepatitis C Virus in Patients Coinfected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 2002
- Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus QuasispeciesJournal of Virology, 2001
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virusJournal of Hepatology, 1997
- Hepatitis C in human immunodeficiency virus-coinfected patients: Increased variability in the hypervariable envelope coding domainHepatology, 1996
- Marked sequence diversity in the putative envelope proteins of hepatitis C virusesVirus Research, 1992